We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
+23.93%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$86.5M
AUM Growth
+$6.47M
Cap. Flow
-$12.7M
Cap. Flow %
-14.73%
Top 10 Hldgs %
33.2%
Holding
120
New
33
Increased
16
Reduced
36
Closed
30

Top Buys

Rank Stock Value
1
SYK icon
Stryker
SYK
+$2.09M
2
AGN
Allergan plc
AGN
+$1.67M
3
WCG
Wellcare Health Plans, Inc.
WCG
+$1.52M
4
PFE icon
Pfizer
PFE
+$1.42M
5
UNH icon
UnitedHealth
UNH
+$1.12M

Top Sells

Rank Stock Value
1
ALLK
Allakos
ALLK
+$4.3M
2
UBX
Unity Biotechnology
UBX
+$3.43M
3
NTGN
Neon Therapeutics, Inc. Common Stock
NTGN
+$2.48M
4
BLK icon
Blackrock
BLK
+$1.71M
5
GDDY icon
GoDaddy
GDDY
+$1.69M

Sector Composition

Rank Sector Weight
1 Healthcare 49.24%
2 Miscellaneous 19.53%
3 Technology 17.92%
4 Communication Services 6.41%
5 Consumer Discretionary 5.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QCOM icon
1
CALL
Qualcomm
QCOM
$175B
$5.72M 6.61%
+100,300
New +$5.41M
QQQ icon
2
PUT
Invesco QQQ Trust
QQQ
$489B
$4.37M 5.05%
+24,300
New +$4.12M
MCHP icon
3
Microchip Technology
MCHP
$39.6B
$2.58M 2.98%
62,222
+8,272
+15% +$343K
GDDY icon
4
GoDaddy
GDDY
$12.4B
$2.45M 2.83%
32,538
-23,994
-42% -$1.69M
ZBH icon
5
Zimmer Biomet
ZBH
$19.2B
$2.43M 2.81%
19,601
+6,573
+50% +$747K
NTGN
6
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
$2.32M 2.68%
359,125
-473,233
-57% -$2.48M
SYK icon
7
Stryker
SYK
$127B
$2.29M 2.65%
+11,607
New +$2.09M
UNH icon
8
UnitedHealth
UNH
$353B
$2.23M 2.58%
9,035
+4,381
+94% +$1.12M
HUM icon
9
CALL
Humana
HUM
$46.3B
$2.18M 2.52%
+8,200
New +$2.36M
PFE icon
10
Pfizer
PFE
$159B
$2.16M 2.5%
53,611
+35,425
+195% +$1.42M
ALNA
11
DELISTED
Allena Pharmaceuticals
ALNA
$2.08M 2.41%
296,961
-4,928
-2% -$35.7K
INTU icon
12
Intuit
INTU
$97.9B
$2M 2.31%
7,651
+1,271
+20% +$294K
ELV icon
13
Elevance Health
ELV
$85.5B
$1.99M 2.3%
6,928
-1,794
-21% -$519K
HUM icon
14
Humana
HUM
$46.3B
$1.94M 2.24%
7,287
-615
-8% -$177K
ARNA
15
DELISTED
Arena Pharmaceuticals Inc
ARNA
$1.82M 2.1%
40,605
+1,197
+3% +$54.9K
NYT icon
16
New York Times
NYT
$11B
$1.72M 1.99%
52,307
+31,430
+151% +$930K
AGN
17
DELISTED
Allergan plc
AGN
$1.68M 1.95%
+11,505
New +$1.67M
PYPL icon
18
PayPal
PYPL
$45.9B
$1.62M 1.87%
15,567
-8,822
-36% -$835K
WCG
19
DELISTED
Wellcare Health Plans, Inc.
WCG
$1.58M 1.83%
+5,866
New +$1.52M
TMO icon
20
Thermo Fisher Scientific
TMO
$230B
$1.54M 1.78%
5,630
+554
+11% +$138K
WCG
21
CALL
DELISTED
Wellcare Health Plans, Inc.
WCG
$1.43M 1.65%
+5,300
New +$1.37M
XYZ
22
Block Inc
XYZ
$50.2B
$1.32M 1.53%
17,641
+4,305
+32% +$312K
ICUI icon
23
ICU Medical
ICUI
$4.38B
$1.32M 1.52%
5,499
+3,202
+139% +$768K
EW icon
24
Edwards Lifesciences
EW
$52B
$1.28M 1.49%
20,151
-11,199
-36% -$639K
PEN icon
25
Penumbra
PEN
$12.7B
$1.2M 1.38%
8,144
-3,202
-28% -$458K
1
2 3 4 5

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
FIM
FourPoints Investment Managers Paris, France $21.1M AUM 11.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BHC
Balch Hill Capital San Francisco, California $22.8M AUM

Partner Investment Management's Q1 2019 Portfolio in Review

As of Q1 2019, Partner Investment Management held 120 positions worth $86.5M, up 8.1% from $80.1M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Partner Investment Management withdrew a net $12.7M in Q1 2019, closing 30 positions and reducing 36 holdings. Its most notable exit was Allakos, an estimated $4.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 49% of assets, down from 57% a quarter earlier, followed by Miscellaneous and Technology.

Against the trend, Partner Investment Management opened a new position in Stryker worth $2.29M.

  • Partner Investment Management's largest Q1 2019 buy was Stryker: 11,607 shares worth $2.29M.
  • Partner Investment Management added most to Pfizer in Q1 2019, an estimated $1.42M increase.
  • Partner Investment Management's biggest Q1 2019 reduction was Unity Biotechnology, cutting an estimated $3.43M.
  • Partner Investment Management fully exited Allakos in Q1 2019, selling an estimated $4.3M.
  • Partner Investment Management's ten largest holdings make up 33% of its $86.5M portfolio in Q1 2019.
  • Partner Investment Management opened 33 new positions and closed 30 in Q1 2019.
  • Partner Investment Management's portfolio value rose 8.1% quarter-over-quarter to $86.5M.

Based on Partner Investment Management's 13F filing for Q1 2019, filed 15 May 2019.